Christopher Lindblom Email & Phone Number

Boston, Massachusetts, United States

Boston, Massachusetts, US

Critical role for Finance and Legal due diligence related to Novartis M&A for IFM Due (STING program). Key contact with Novartis throughout collaboration, acquisition and transition. Management team member and presenter at Board meetings. Sublet unused space in 2022 through end of facility lease in 2024.

Cambridge, Massachusetts, US

Member of Management Team. Played key role in equity financing and amending venture debt agreement.

Boston, Massachusetts, US

Member of Management Team who made several operational improvements including implementing Prendio, further optimizing NetSuite to include all subsidiaries for the full LLC structure and using Carta for the first time on several legal entities. Led lean team of consultants to better serve the company's needs. Presented at Board meetings. Played key role in.

Executed M&A with another Flagship company (Torque) to form Repertoire Immune Medicines and implemented financial integration activities. Worked closely with Flagship and investors on $100+ million Series B equity raise. Created long range financial plan highlighting value inflection points and capital requirements. Played key role on Management team..

Played significant part with CEO in M&A with Revolution Medicines, Inc. during Series B equity raise process. Member of Management Team who built strong relationships with R&D. Led long-range planning and budgeting / forecasting with focus on value creation inflection points. Presented at board meetings and managed yearly audit / audit committee processes..

Cambridge, Massachusetts, US

Planned and organized financial infrastructure and processes in preparation for pharmaceutical commercial launch until dramatic downsizing after registration oriented data read-outs and termination of strategic collaboration with AbbVie. Identified and retained critical finance roles to maintain transition to a smaller company focused on an Phase 1 program.

Cambridge, MA, US

Played key role in confidentially marketed equity raise, at-the-market facility and venture debt. Spoke regularly on quarterly earnings conference calls with investors. Strong member of management team. Led all Audit Committee meetings and presented at quarterly Board of Director meetings.Reshaped and supervised diverse team including the Controller.

Built finance team and efficiently executed Sarbanes-Oxley compliance and SEC / management reporting. Prime contributor in all Audit Committee meetings and presenter at Board of Director meetings. Finance member of the executive management team.Selected and implemented NetSuite cloud ERP system to replace QuickBooks. Strengthened income statement and long.

Cambridge, Massachusetts, US

Built in three months’ time, for this oncology-focused company that went public via a reverse merger in 2006, a Sarbanes-Oxley compliant accounting team and robust SEC / management reporting processes. Key leader in team that successfully executed two confidentially marketing equity offerings exceeding $250M in total proceeds. Prime contributor in all.

Cambridge, MA, US

Revamped accounting, cost accounting and accounts payable teams and processes to enhance alignment and performance both with business groups and with Financial Planning in a highly matrixed organization (functions as well as products). Led product sales accounting (returns reserve, chargeback reserve, revenue recognition, and government pricing)..

Boston, Massachusetts, US

Upgraded and executed financial and operating reporting and metrics for sales organization. Modeled potential acquisitions and competitive analysis.

Prepared financial reporting packages for management and SEC reporting. Supported public debt offering and The Neiman Marcus Group, Inc. spin-off.

GB

Served as Field Team Leader on assurance engagements for High-Tech, Manufacturing and Non-Profit.

Master Of Business Administration - Mba

Bachelor Of Science - Bs, Accounting